Medication info
Megaspen Tablet

Megaspen Tablet

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›37.5mg / 1 tabletAcetaminophen›325mg / 1 tablet
Manufacturer / importer
Kyungdong Pharmaceutical Co., Ltd.
Appearance
Pale yellow oblong film-coated tablets
Packaging
For domestic use: 30 tablets/bottle, 100 tablets/bottle; for export: 100 tablets (10 tablets/PTP x 10)
Approval status
Active

MFDS item code 200804802 · Notified 2008.04.28 · Insurance code 648102530

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: Adjust the dose according to the patient's level of pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should continue. Elderly patients Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance below 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, without exceeding 8 tablets per day. Use the lowest effective dose for the shortest possible period. Do not use this medicine for longer than necessary. If long-term use is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
Kyungdong Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used to relieve moderate to severe acute and chronic pain.

How to take

Adult dose

Adults: Adjust the dose according to the patient's level of pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should continue. Elderly patients Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance below 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, without exceeding 8 tablets per day. Use the lowest effective dose for the shortest possible period. Do not use this medicine for longer than necessary. If long-term use is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Precautions

This medication can exert stress on the liver, so individuals who regularly consume more than three drinks a day should consult a doctor or pharmacist before taking it. It contains acetaminophen, which can rarely cause serious skin allergic reactions, so if any skin rash or hypersensitivity occurs, discontinue use immediately and consult a healthcare professional. The tramadol component can induce seizures; therefore, individuals with a history of seizures or those at risk of seizures should exercise caution, as the risk may increase when taken with certain antidepressants or other opioid analgesics. For patients with asthma and compromised respiratory function, this medication can pose risks and should be administered under medical supervision, considering alternatives like non-opioid analgesics. Combining with alcohol or benzodiazepines can lead to severe drowsiness, respiratory depression, and coma, so it should be used with extreme caution in such cases. Patients with increased intracranial pressure or head injuries need to be cautious as the respiratory-depressant effect of this medication may worsen their condition. This medication may cause dependence similar to morphine, thus requiring careful use to prevent potential dependence with prolonged use. Patients with impaired liver function may suffer liver damage due to the acetaminophen included in this medication, so they must consult with a doctor prior to use. Particularly, those with a variant of the CYP2D6 enzyme that acts very quickly need to be cautious, as the components of this medication may activate rapidly in their bodies, increasing the risk of respiratory depression. It is safest not to use this medication in children under 12 years old and adolescents under 18 who have undergone tonsillectomy or adenoidectomy. Patients with sleep apnea or hypoxemia may experience worsening symptoms after taking this medication, thus requiring continuous observation and dose adjustment as necessary. Elderly patients or those at risk for hyponatremia should be closely monitored for symptoms of hyponatremia while taking this medication. This medication has multiple drug interactions; therefore, anyone taking other medications must inform their physician, especially if using MAO inhibitors, antidepressants, antibiotics, or antifungals. Pregnant or breastfeeding women should consult with healthcare professionals before using this medication, as infants may experience sedation or respiratory depression as side effects during breastfeeding requiring monitoring. This medication may cause drowsiness or dizziness, necessitating caution when driving or operating machinery, and using it with alcohol may exacerbate these symptoms. In the case of overdose, severe respiratory depression, seizures, and liver damage may occur, thus the prescribed dosage must be strictly adhered to, and if overdose is suspected, immediate medical attention is required. This medication must be stored in a secure location out of the reach of children to prevent misuse or accidents.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, hepatotoxicity, hyponatremia, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, indigestion, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, irritability, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, spatial disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, hypersomnia, sensory reduction, tremor, paresthesia, attention deficit, syncope, memory impairment, psychomotor hyperactivity, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweats, urinary disorders, erectile dysfunction, asthenia, chest pain, emotional abnormality, chills, chest discomfort, malaise, thirst, irritability, warmth sensation, weight loss, increased blood creatinine, anaphylaxis reaction, unstable emotions, delirium, suicidal thoughts, muscular hypertonicity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, walking disturbances, prolonged prothrombin time, thrombocytopenia, anemia, decreased hemoglobin, decreased red blood cells, leukopenia, leukocytosis, congestive heart failure, vertigo, stupor, confusion, multiple organ failure, loss of consciousness, recurrent myocardial infarction, hypotension, bleeding, elevated cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, epistaxis, abnormal vision, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, liver function abnormalities, cholecystitis, paralytic ileus, hiccups, abnormal kidney function tests, increased saliva, nausea, constipation, vomiting, indigestion, abdominal pain, dry mouth, diarrhea, dysphagia, flatulence, tongue swelling, increased saliva, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, asthenia, fever, edema, chest pain, stiffness, syncope, drowsiness, insomnia, loss of appetite, anxiety, depression, irritability, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, leukopenia, leukocytosis, thrombocytopenia, palpitations, hypertension, arrhythmia, tachycardia, worsening hypertension, aortic stenosis, bleeding, elevated cholesterol, weight loss, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, epistaxis, abnormal vision, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, liver function abnormalities, nausea, dizziness, seizures, respiratory depression, hypersomnia, coma, cardiac arrest, QT prolongation, liver failure, renal tubular necrosis, hypoglycemia, coagulation disorders, abdominal discomfort, malaise, pallor, hyperhidrosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture exposure, preferably at a temperature between 1 and 30 degrees Celsius. Proper storage aids in maintaining the drug's effectiveness and prevents degradation.

Appearance and packaging

Appearance

Pale yellow oblong film-coated tablets

Package unit

For domestic use: 30 tablets/bottle, 100 tablets/bottle; for export: 100 tablets (10 tablets/PTP x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.